David S Liu. PhD, FRACS

CALLLING all Allied Health and Nurses interested in Upper GI diseases. We are offering 2 bursaries to support any Allied Health and Nurses attend the AANZGOSA ASM, on 17 Sept, Brisbane. Visit: aanzgosa-asm.com/travel-bursary/ Early bird: ends 14th August See you in Brisbane! @aanzgosa

Posted this now @biorxivpreprint ! A comprehensive effort from @mcgillu detailing progressive refinement of gastroesophageal adenocarcinoma patient-derived #organoid generation. A huge bio repository of almost 400 patient tumours! @organoidscience biorxiv.org/content/10.110…

🌆 Don’t miss the #ISDE2025 Congress Dinner on Sept 19! Dine above #Brisbane at the Sky Room with iconic views, Aussie flavors, live entertainment & great company. 📍 BCEC 🕖 7–10PM 👔 Biz casual 💵 $165 USD Secure your spot now👉isde-congress.net/registration/ #esophagus #esophageal

🚨 1 Week Left! Early bird registration for #ISDE2025 closes June 12! Join global experts in esophageal health Sept 18–20 in Brisbane 🇦🇺 ✅ Save up to $100 ✅ Top hotels still available ✅ Cutting-edge science & networking isde-congress.net/registration/ #ISDE #esophagus #esophageal

Matterhorn is out! Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

First trial of CAR-T cell ca tx for solid tumor response: @ASCO #ASCO25 Satricabtagene autoleucel (satri-cel)/CT041 demonstrated significant progression-free survival (PFS) improvement and a clinically meaningful overall survival (OS) benefit in patients with previously treated,…

I disagree with the statement that nivo demonstrated OS survival improvement in Checkmate577, when the CI overlaps 1! I agree nivo is a clinically useful agent after CRT, especially for esoph SCC. While an ⬆️ OS is plausible, the data presented do not prove it.

#ASCO25 OG orals take homes: 1. CM577: adj nivo SCC only 🚫 mixed histology trials! 2. LEAP15: chemo+TKI+ICI=too much 🔎 Attention to the safety run-in 3. DG04: TDXD 1.1m PFS 3.3m OS ⬆️ 💉biopsy after 1L 4. CLD 18.2 CAR-T: 4m PFS 🔬 More work needed on tox vs efficacy

🚨DYNAMIC-III🚨 🔎R0 resected stage 3 colon cancer, post-op ctDNA + Randomized SoC vs intensified Systemic therapy ⛔️No improvement in RFS with intensification 🧐While ctDNA+ is prognostic, work is needed to identify how tx/selection may be altered to ⬆️outcomes #ASCO25

What is the optimal length of POEM for achalasia? "Standard length of peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis" ow.ly/fmLZ50Vr3x9

Hot off the press! "International Society for Diseases of the Esophagus consensus on management of the failed fundoplication" #GERD #SoMe4Surgery #ISDE #EsophagealSurgery ow.ly/qWpL50Vr3wj

Exciting to annouce, Young ISDE @ISDE_net @AfrinKamalMD @JessieAElliott has activated a database for international fellowships in esophageal diseases - for surg, gastro, scientist, allied health etc. Please enter your centre's data and spread the word. isde.net/fellowship-opp…

⁦@mivanbh⁩ opening the European Society for Diseases of the Esophagus meeting in #amsterdam. Outstanding program over 2 days on all things esophageal.

Abstracts submissions are open for the AANZGOSA ASM, 17 Sept Brisbane, just before ⁦@ISDE_net⁩ congress. Don’t miss this opportunity to present your findings to a truely international audience! ⁦@LisaMurnane7⁩ submit: aanzgosa-asm.com/abstracts/ aanzgosa-asm.com

#ISDE President, Prof. Lorenzo Ferri @LFerri123 invites all professionals interested in esophageal diseases to join #ISDE2025 in Brisbane 📅Sep 18-20. Hear his message at vimeo.com/1070081528?sha… 📷Learn from the best in #esophagus #esophagealcancer @DOTEsophagus @young_esde

The @NIH is adopting an initiative to expand human-based models like Organ Chips. This tech, commercialized by @emulateinc, enables faster, better, & cheaper drug development. We'll see more successful clinical trials & better treatments. nih.gov/news-events/ne…

Supported by a £2million NIHR-funded Research Professorship, Rebecca Fitzgerald, Professor of Cancer Prevention at the @Cambridge_Uni , developed a quick, accurate and low-cost test that is enabling early detection of Barrett’s oesophagus, the precursor to oesophageal cancer.…

Enjoying the benign upper gi debates - routine HRM prior to ARS - yes or no? @DrDavidSLiu doing a great job at arguing the AGAINST position! @RACSurgeons #ASC2025

Waited long time for this #RCT comparing pyloroplasty and no pyloroplasty in #MIE #RAMIE 👉pyloroplasty @SSATNews @FellowshpCouncl @SESC_AmSurg @EmorySurgery @MarkarSheraz @ISDE_net @SAGES_Updates @STS_CTsurgery @DOTEsophagus @ForegutSociety @PittSurgery